We provide complete regulatory compliance solutions for homeopathic medicines in the USA.
We assist startups and existing companies with FDA NDC Labeler Code Requests, US Drug Listing (DRLS), Label Compliance, Drug Facility Registration and Annual Registration Renewal. Get the information and guidance you need to meet all regulatory requirements and obtain NDC labeler codes for your drug products.
Drugs are recognized and reported using a unique, three-segment number assigned by the FDA. This three-segment number is called the National Drug Code (NDC labeler code) and serves as the FDA’s identifier for drugs. The NDC labeler code also helps consumers and compliance enforcement experts to identify medicines sold in the USA.
Further, NDC labeler codes identify the pharmaceutical firm, repackager, or distributor as well as the type of drug product with the active ingredient and the package type and size. Any product that has been classified as a drug and is marketed without an NDC does not cater to the FDA’s requirements and is considered to pose a risk to consumers/patients.
Proven Expertise. Companies that have put their faith in us to help them comply with the regulations.
No drug products, including homeopathic medicines, in the USA can be sold without meeting the applicable drug product regulations. Drugs without an NDC Labeler Code mean the FDA has not reviewed them for safety and effectiveness.
According to this Act, every registered Drug Establishment must provide the FDA with a list of drugs they currently manufacture, propagate, prepare, or process for commercial sale or distribution.
The FDA publishes the listed NDC Labeler Code numbers in the NDC Directory, which has information on active and certified finished drug products. The FDA updates this directory daily.
We provide quick assistance at the right time to help you meet homeopathic drug regulations in the USA. Our range of homeopathic drug compliance solutions for the USA includes: We help clients adhere to US Drug Label Regulations for homeopathic medicines by making them aware of any labelling requirements and changes. We provide assistance with managing your establishment registrations, followed by submitting an application to the FDA.
Health Canada’s Natural and Non-Prescription Health Products Directorate (NNHPD) has opened a Health Canada monograph consultation for two botanicals: black cumin (Nigella sativa) and tongkat ali (Eurycoma longifolia). Stakeholders have until
... Read more
The U.S. Food and Drug Administration (FDA) has taken a significant step forward in its post-market reassessment of phthalates used in food contact materials, signaling
... Read more
The U.S. Food and Drug Administration has released updated guidance for AI-enabled medical devices that reshapes how manufacturers must approach the development, validation, and lifecycle management
... Read more
Health Canada has amended the Prescription Drug List (PDL) to require a prescription for all sleep-related use of melatonin in children and adolescents under 18
... Read more
